All tumors must overcome an angiogenic barrier as they progress to malignancy. This barrier is maintained by a variety of molecules that are natural inhibitors of angiogenesis and serve to block the sprouting of new blood vessels in most normal adult tissues. The PI has recently discovered a new and exceptionally potent natural inhibitor of angiogenesis that is highly expressed in the normal retina , but lost in several pediatric tumors and identified it as a 50 kDa protein that had been previously cloned in another context. This proposal outlines experiments designed to understand how this inhibitor works, how it is regulated during tumor progression and what role it plays in the angiogenesis associated with childhood malignancies and in eye diseases. The mechanism by which the new inhibitor blocks angiogenesis will be identified along with the site on the protein that mediates its anti-angiogenic activity. This new inhibitor is unique among the previously identified inhibitors in that its production by cells is inhibited by hypoxia, so the mechanism underlying this suppression will be studied to determine if it is widespread, if it is dependent on an oxygen sensor and to learn the molecular level at which control is exerted. To determine the general function of this protein, a mouse expressing beta-galactosidase in its place is being produced and will be used to investigate expression patterns and effects of loss of the inhibitor on gross and microscopic anatomy, on normal vascular development, and on tumorigenesis. Finally the expression of the anti-angiogenic protein will be examined in a murine model of retinopathy and in neuroblastoma tumors and its ability to control the angiogenic phenotype of primary tumors, their explants and tumor cell lines determined. These experiments will enhance our understanding of how tumors develop and maintain their essential angiogenic phenotype. They have the exciting possibility of defining a new anti-angiogenic agent capable of controlling the growth of vessels that feed malignant tumors and cause the devastating ocular angiogenesis that is a leading cause of blindness.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA064239-08S1
Application #
6449954
Study Section
Pathology A Study Section (PTHA)
Program Officer
Rosenfeld, Bobby
Project Start
1994-07-01
Project End
2004-02-29
Budget Start
2001-07-01
Budget End
2002-02-28
Support Year
8
Fiscal Year
2001
Total Cost
$5,596
Indirect Cost
Name
Northwestern University at Chicago
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Qi, Wentao; Fitchev, Philip S; Cornwell, Mona L et al. (2013) FOXO3 growth inhibition of colonic cells is dependent on intraepithelial lipid droplet density. J Biol Chem 288:16274-81
Grippo, Paul J; Fitchev, Philip S; Bentrem, David J et al. (2012) Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut 61:1454-64
Schmitz, John C; Protiva, Petr; Gattu, Arijeet K et al. (2011) Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1. Am J Pathol 179:2990-9
Chung, Chuhan; Mader, Christopher C; Schmitz, John C et al. (2011) The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest 91:732-43
Fitchev, Philip P; Wcislak, Susan M; Lee, Chung et al. (2010) Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation. Lab Invest 90:1078-90
Chung, Chuhan; Doll, Jennifer A; Gattu, Arijeet K et al. (2008) Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol 48:471-8
Abramson, Lisa P; Browne, Marybeth; Stellmach, Veronica et al. (2006) Pigment epithelium-derived factor targets endothelial and epithelial cells in Wilms' tumor. J Pediatr Surg 41:1351-6
Browne, Marybeth; Stellmach, Veronica; Cornwell, Mona et al. (2006) Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model. Pediatr Res 60:282-7
Freeman, A F; Crawford, S E; Cornwall, M L et al. (2005) Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 26:578-84
Huang, Hanhua; Campbell, Steven C; Bedford, Dhugal F et al. (2004) Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. Mol Cancer Res 2:541-50

Showing the most recent 10 out of 48 publications